The experimental approaches outlined in these application notes support several key research applications in cardiovascular drug discovery and nutraceutical development: Recent advances in in vitro atherosclerosis modeling , including sophisticated 3D systems, tissue-engineered blood vessels, and vessel-on-a-chip technologies, offer enhanced physiological context for future this compound research [1]
It protects neurons from oxidative damage, supports mitochondrial function, and may reduce the risk of neurodegenerative diseases such as Alzheimers and Parkinsons
Constipation On the opposite end, constipation affected 24.2% of semaglutide 2.4 mg users versus 11.1% on placebo in the STEP trials
Hamlin, J.C., et al
A combination of effects on CV risk factors and direct effect on the process of atherosclerosis are supported by preclinical studies where GLP-1RA showed anti-atherosclerotic and anti-inflammatory effects and improved endothelial function [73]
As with any medication, side effects are possible